Product NDC: | 68462-158 |
Proprietary Name: | Ondansetron |
Non Proprietary Name: | Ondansetron |
Active Ingredient(s): | 8 mg/1 & nbsp; Ondansetron |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68462-158 |
Labeler Name: | Glenmark Generics Inc., USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078152 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070627 |
Package NDC: | 68462-158-11 |
Package Description: | 10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-11) |
NDC Code | 68462-158-11 |
Proprietary Name | Ondansetron |
Package Description | 10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-11) |
Product NDC | 68462-158 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20070627 |
Marketing Category Name | ANDA |
Labeler Name | Glenmark Generics Inc., USA |
Substance Name | ONDANSETRON |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |